Drugs / Trimo-San
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01471457 | Sep 2009 → Sep 2014 | bacterial vaginosis | University of New Mexico | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03943823 Comparator | May 2019 → Mar 2021 | bacterial vaginosis, vaginal discharge | The University of Texas Health Science Center, Houston | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TrimoSan | “The aim of this study was to evaluate the effect of TrimoSan gel (Milex Pessaries, Cooper Surgical, Trumbull, CT) on BV prevalence among pessary users.” PMID 25935783 ↗ Apr 2015 |
| Route | Other | “Trimo-San vaginal gel” NCT03943823 ↗ |